Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) Cash from Investing Activities (2020 - 2024)

Historic Cash from Investing Activities for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$45.9 million.

  • ImageneBio's Cash from Investing Activities fell 32537.79% to -$45.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$34.9 million, marking a year-over-year decrease of 15441.35%. This contributed to the annual value of -$34.9 million for FY2024, which is 15441.35% down from last year.
  • ImageneBio's Cash from Investing Activities amounted to -$45.9 million in Q4 2024, which was down 32537.79% from $55.8 million recorded in Q3 2024.
  • ImageneBio's Cash from Investing Activities' 5-year high stood at $55.8 million during Q3 2024, with a 5-year trough of -$166.1 million in Q1 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was $1000.0 (2020), whereas its average is -$3.6 million.
  • Data for ImageneBio's Cash from Investing Activities shows a peak YoY increase of 1954673.91% (in 2022) and a maximum YoY decrease of 1969153.75% (in 2022) over the last 5 years.
  • ImageneBio's Cash from Investing Activities (Quarter) stood at $3.0 million in 2020, then plummeted by 118.1% to -$550000.0 in 2021, then soared by 2008.91% to $10.5 million in 2022, then skyrocketed by 94.08% to $20.4 million in 2023, then tumbled by 325.38% to -$45.9 million in 2024.
  • Its Cash from Investing Activities was -$45.9 million in Q4 2024, compared to $55.8 million in Q3 2024 and $3.9 million in Q2 2024.